Generic Drugs Access Act of 2005
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Generic Drugs Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to include in an approval of an abbreviated application for a new drug a finding about whether the approved drug is the therapeutic equivalent of the previously approved or listed drug involved. Sets forth criteria for a drug to be established as therapeutically equivalent.
Prohibits a state or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2299: Generic Drugs Access Act of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-HR-2299/
"H.R. 2299: Generic Drugs Access Act of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-2299/.
H.R. 2299, 109th Cong. (2026), https://openamerica.io/bill/109-HR-2299/.
[H.R. 2299: Generic Drugs Access Act of 2005](https://openamerica.io/bill/109-HR-2299/)